International Journal of Research and Scientific Innovation (IJRSI)
Comprehensive Review on Analytical Method Development and Validation of Rosuvastatin Calcium
Published April 25, 2026 • Vol. 13, Issue 3, pp. 2753–2761Open Access
DOI: 10.51244/IJRSI.2026.1303000239
Abstract
Rosuvastatin Calcium is a potent antihyperlipidemic drug belonging to the class of HMG-CoA reductase inhibitors i.e statins. It acts by selectively inhibiting the enzyme 3-hydroxy-3methylglutaryl coenzyme A (HMG-CoA) reductase, which is responsible for cholesterol synthesis which helps in increasing LDL clearance from blood. The present review focuses on the different Analytical Method Development of Rosuvastatin and QbD based approaches.
Keywords: Rosuvastatin Calcium, Antihyperlipidemic
| Journal | International Journal of Research and Scientific Innovation (IJRSI) |
|---|---|
| ISSN | 2321-2705 |
| Volume / Issue | Volume 13, Issue 3 |
| Pages | 2753–2761 |
| Publication date | April 25, 2026 |
| DOI | 10.51244/IJRSI.2026.1303000239 |
| Publisher | RSIS International |
| License | Open Access |
How to cite this article
Muskan Mulla, Dr. Uday A. Deokate, Pratiksha Kamble, Vaishnavi Punase, & Lalit Bhoye (2026). Comprehensive Review on Analytical Method Development and Validation of Rosuvastatin Calcium. International Journal of Research and Scientific Innovation (IJRSI), 13(3), 2753-2761. https://doi.org/10.51244/IJRSI.2026.1303000239
BibTeX
@article{Muskan2026,
title = {Comprehensive Review on Analytical Method Development and Validation of Rosuvastatin Calcium},
author = {Muskan Mulla and Dr. Uday A. Deokate and Pratiksha Kamble and Vaishnavi Punase and Lalit Bhoye},
journal = {International Journal of Research and Scientific Innovation (IJRSI)},
volume = {13},
number = {3},
pages = {2753--2761},
year = {2026},
doi = {10.51244/IJRSI.2026.1303000239},
publisher = {RSIS International}
}